CHEK2 and breast carcinoma: Prior large studies of patients undergoing multigene panel testing have, however, identified modest associations with early-onset breast cancer and GPVs in ATM and CHEK2,32 and it should be emphasized that our study was not specifically powered to detect demographic or clinical factors associated with a GPV in these and other secondary panel genes.